The results revealed that invasive breast carcinoma patients with reduced GPD1 mRNA have significantly reduced overall survival (p = 0.024, Figure 6C), which is consistent with our meta-analyses of the microarray datasets. The gene discussed is GPD1; the disease is invasive breast carcinoma.